Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.

Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, Gao X, Cozen W, Rothman N, Davis S, Severson RK, Bernstein L, Hartge P, Carrington M.

Blood. 2010 Jun 10;115(23):4820-3. doi: 10.1182/blood-2010-01-266775. Epub 2010 Apr 12.

2.

Human leukocyte antigens and genetic susceptibility to lymphoma.

McAulay KA, Jarrett RF.

Tissue Antigens. 2015 Aug;86(2):98-113. doi: 10.1111/tan.12604. Review.

PMID:
26189878
3.

Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.

Wang SS, Lu Y, Rothman N, Abdou AM, Cerhan JR, De Roos A, Davis S, Severson RK, Cozen W, Chanock SJ, Bernstein L, Morton LM, Hartge P.

PLoS One. 2011;6(11):e26949. doi: 10.1371/journal.pone.0026949. Epub 2011 Nov 9.

4.

Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.

Nowak J, Kalinka-Warzocha E, Juszczyński P, Mika-Witkowska R, Zajko M, Graczyk-Pol E, Coiffier B, Salles G, Warzocha K.

Tissue Antigens. 2008 Jan;71(1):16-26. Epub 2007 Oct 29.

PMID:
17971052
5.

Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma.

Skibola CF, Akers NK, Conde L, Ladner M, Hawbecker SK, Cohen F, Ribas F, Erlich HA, Goodridge D, Trachtenberg EA, Smith MT, Bracci PM.

Tissue Antigens. 2012 Apr;79(4):279-86. doi: 10.1111/j.1399-0039.2012.01845.x. Epub 2012 Feb 2.

6.

Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.

Choi HB, Roh SY, Choi EJ, Yoon HY, Kim SY, Hong YS, Kim DW, Kim TG.

Int J Hematol. 2008 Mar;87(2):203-9. doi: 10.1007/s12185-008-0040-4. Epub 2008 Feb 27.

PMID:
18301962
7.

HLA class II polymorphism in Egyptian children with lymphomas.

Al-Tonbary Y, Abdel-Razek N, Zaghloul H, Metwaly S, El-Deek B, El-Shawaf R.

Hematology. 2004 Apr;9(2):139-45.

PMID:
15203870
8.

Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.

Lu Y, Abdou AM, Cerhan JR, Morton LM, Severson RK, Davis S, Cozen W, Rothman N, Bernstein L, Chanock S, Hartge P, Wang SS.

ScientificWorldJournal. 2011;11:2062-70. doi: 10.1100/2011/373876. Epub 2011 Nov 1.

9.

Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.

Kurzwelly D, Müller CA, Korfel A, Thiel E, Linnebank M, Weller M, Herrlinger U.

J Neurooncol. 2008 Oct;90(1):53-5. doi: 10.1007/s11060-008-9630-5. Epub 2008 Jun 28.

PMID:
18587537
10.

A preliminary study of HLA class II alleles in Thai patients with non Hodgkin's lymphoma.

Nathalang O, Tatsumi N, Hino M, Yamane T, Prayoonwiwat W, Suwanasophon C, Sriphaisal T.

Osaka City Med J. 1997 Dec;43(2):253-8.

PMID:
9540346
11.

HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma.

Sayad A, Akbari MT, Mehdizadeh M, Taheri M, Hajifathali A.

Iran J Immunol. 2014 Dec;11(4):269-74. doi: IJIv11i4A5.

PMID:
25549594
12.

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.

Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, Kumar V, Chang ET, Rothman N, Cerhan JR, Brooks-Wilson AR, Rehnberg E, Irwan ID, Ryder LP, Brown PN, Bracci PM, Agana L, Riby J, Cozen W, Davis S, Hartge P, Morton LM, Severson RK, Wang SS, Slager SL, Fredericksen ZS, Novak AJ, Kay NE, Habermann TM, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Leach S, Spinelli JJ, Smith MT, Chanock SJ, Padyukov L, Alfredsson L, Klareskog L, Glimelius B, Melbye M, Liu ET, Adami HO, Humphreys K, Liu J.

PLoS Genet. 2011 Apr;7(4):e1001378. doi: 10.1371/journal.pgen.1001378. Epub 2011 Apr 21.

13.

Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.

Johnson PC, McAulay KA, Montgomery D, Lake A, Shield L, Gallagher A, Little AM, Shah A, Marsh SG, Taylor GM, Jarrett RF.

Int J Cancer. 2015 Sep 1;137(5):1066-75. doi: 10.1002/ijc.29467. Epub 2015 Feb 20.

14.

Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.

Wang SS, Menashe I, Cerhan JR, Cozen W, Severson RK, Davis S, Hutchinson A, Rothman N, Chanock SJ, Bernstein L, Hartge P, Morton LM.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):42-9. doi: 10.1158/1055-9965.EPI-10-0638. Epub 2010 Dec 10.

15.

HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.

Trachtenberg E, Vinson M, Hayes E, Hsu YM, Houtchens K, Erlich H, Klitz W, Hsia Y, Hollenbach J.

Tissue Antigens. 2007 Dec;70(6):455-63. Epub 2007 Sep 27.

PMID:
17900288
16.

HLA class II alleles in Japanese patients with non-Hodgkin's lymphoma.

Nathalang O, Tatsumi N, Hino M, Yamane T, Sriphaisal T.

Southeast Asian J Trop Med Public Health. 2000 Sep;31(3):556-60.

PMID:
11289020
17.

Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.

Lim U, Kocarnik JM, Bush WS, Matise TC, Caberto C, Park SL, Carlson CS, Deelman E, Duggan D, Fesinmeyer M, Haiman CA, Henderson BE, Hindorff LA, Kolonel LN, Peters U, Stram DO, Tiirikainen M, Wilkens LR, Wu C, Kooperberg C, Le Marchand L.

PLoS One. 2014 Mar 5;9(3):e89791. doi: 10.1371/journal.pone.0089791. eCollection 2014 Mar 5.

18.

HLA class II polymorphism in Thai patients with non-Hodgkin's lymphoma.

Nathalang O, Tatsumi N, Hino M, Prayoonwiwat W, Yamane T, Suwanasophon C, Sriphaisal T.

Eur J Immunogenet. 1999 Dec;26(6):389-92.

PMID:
10583459
19.

HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.

De Re V, Caggiari L, Monti G, Libra M, Spina M, Dolcetti R, De Zorzi M, Racanelli V, Crovatto M, Toffoli G.

Tissue Antigens. 2010 Feb;75(2):127-35. doi: 10.1111/j.1399-0039.2009.01414.x. Epub 2009 Dec 9.

PMID:
20002609
20.

Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.

Wang SS, Vajdic CM, Linet MS, Slager SL, Voutsinas J, Nieters A, de Sanjose S, Cozen W, Alarcón GS, Martinez-Maza O, Brown EE, Bracci PM, Lightfoot T, Turner J, Hjalgrim H, Spinelli JJ, Zheng T, Morton LM, Birmann BM, Flowers CR, Paltiel O, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Foretova L, Staines A, Davis S, Severson R, Cerhan JR, Breen EC, Lan Q, Brooks-Wilson A, De Roos AJ, Smith MT, Roman E, Boffetta P, Kricker A, Zhang Y, Skibola C, Chanock SJ, Rothman N, Benavente Y, Hartge P, Smedby KE.

Am J Epidemiol. 2015 Mar 15;181(6):406-21. doi: 10.1093/aje/kwu290. Epub 2015 Feb 23. Review.

Supplemental Content

Support Center